{"id":{"repo_id":"denver","oai_identifier":"oai:digitalcommons.du.edu:etd-1144"},"canonical_url":"https://search.dev.ndltd.org/etd/denver/oai:digitalcommons.du.edu:etd-1144","repository":{"repo_id":"denver","name":"University of Denver","base_url":"https://digitalcommons.du.edu/do/oai/"},"display":{"title":"cAMP and Calcium Interactions in Endocrine Cells","abstract":"<p>Inhibitors of cAMP phosphodiestereses (PDEs) promoted an increase in intracellular [cAMP]<sub>c</sub> and an influx of Ca<sup>2+</sup>, in both MMQ pituitary cells and α-Pancreatic cells. The specific targets for PDEs and the domains of PDEs are still unknown. Pituitary MMQ cells were used as a model to test modulation of calcium influx through the L-type calcium channel with PDE inhibitors. cAMP analogs were used to determine cAMP molecular targets. 8-cpt-cAMP initiated an Epac mediated pathway and had strong effects on calcium influx in the cell; suggesting, a relatively strong cAMP target. Experiments of α-Pancreatic cells were done in 2mM glucose and 8mM glucose to stimulate hypoglycemia and resting states respectively. Ca<sup>2+</sup> induced Ca<sup>2+</sup> release (CICR) was observed when αMSH was applied with the three PDE inhibitors. When αMSH was applied without a PDE inhibitor there was no increase in [cAMP]<sub>c</sub>, suggesting a micro domain. Extracellular solutions of 2mM glucose with PDE inhibitors such as Milironone, there was influx through N-type and L-type channels and then steady CICR. Rolipram decreased the amount of [Ca<sup><sub>2+</sub></sup>]<sub>c</sub> influx compared to the control, suggesting an inhibitory effect. PDE locations within the cell dictate the level of [cAMP]<sub>c</sub> increase and the influx of [Ca<sup>2+</sup>]<sub>c</sub>.</p>","abstract_html":"&lt;p&gt;Inhibitors of cAMP phosphodiestereses (PDEs) promoted an increase in intracellular [cAMP]&lt;sub&gt;c&lt;/sub&gt; and an influx of Ca&lt;sup&gt;2+&lt;/sup&gt;, in both MMQ pituitary cells and α-Pancreatic cells. The specific targets for PDEs and the domains of PDEs are still unknown. Pituitary MMQ cells were used as a model to test modulation of calcium influx through the L-type calcium channel with PDE inhibitors. cAMP analogs were used to determine cAMP molecular targets. 8-cpt-cAMP initiated an Epac mediated pathway and had strong effects on calcium influx in the cell; suggesting, a relatively strong cAMP target. Experiments of α-Pancreatic cells were done in 2mM glucose and 8mM glucose to stimulate hypoglycemia and resting states respectively. Ca&lt;sup&gt;2+&lt;/sup&gt; induced Ca&lt;sup&gt;2+&lt;/sup&gt; release (CICR) was observed when αMSH was applied with the three PDE inhibitors. When αMSH was applied without a PDE inhibitor there was no increase in [cAMP]&lt;sub&gt;c&lt;/sub&gt;, suggesting a micro domain. Extracellular solutions of 2mM glucose with PDE inhibitors such as Milironone, there was influx through N-type and L-type channels and then steady CICR. Rolipram decreased the amount of [Ca&lt;sup&gt;&lt;sub&gt;2+&lt;/sub&gt;&lt;/sup&gt;]&lt;sub&gt;c&lt;/sub&gt; influx compared to the control, suggesting an inhibitory effect. PDE locations within the cell dictate the level of [cAMP]&lt;sub&gt;c&lt;/sub&gt; increase and the influx of [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;sub&gt;c&lt;/sub&gt;.&lt;/p&gt;","abstract_has_math":false,"creators":["Crane, Colette"],"institution":null,"degree_name":"M.S.","degree_level":"Masters Thesis","degree_discipline":null,"degree_department":null,"school":null,"contributors":["Joseph K. Angleson, Ph.D.","Robert Dores","Nancy Lorenzon","Dwight Smith"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2011,"date_issued":"2011-06-01T07:00:00Z","date_published":"2011-06-01T07:00:00Z","updated_at":"2026-07-24T02:03:03Z","subjects":["Inhibitors of cAMP phosphodiestereses","Modulation of calcium influx","Endocrine cells","Biology","Life Sciences"],"languages":["en"],"rights":["<p>Copyright is held by the author. User is responsible for all copyright compliance.</p>"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.du.edu/etd/145","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Joseph K. Angleson, Ph.D.","Robert Dores","Nancy Lorenzon","Dwight Smith"]},{"key":"dc:creator","label":"Author","values":["Crane, Colette"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2001-01-01T08:00:00Z"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Masters Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["M.S."]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Inhibitors of cAMP phosphodiestereses","Modulation of calcium influx","Endocrine cells","Biology","Life Sciences"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["<p>Copyright is held by the author. User is responsible for all copyright compliance.</p>"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.du.edu/etd/145"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>Inhibitors of cAMP phosphodiestereses (PDEs) promoted an increase in intracellular [cAMP]<sub>c</sub> and an influx of Ca<sup>2+</sup>, in both MMQ pituitary cells and α-Pancreatic cells. The specific targets for PDEs and the domains of PDEs are still unknown. Pituitary MMQ cells were used as a model to test modulation of calcium influx through the L-type calcium channel with PDE inhibitors. cAMP analogs were used to determine cAMP molecular targets. 8-cpt-cAMP initiated an Epac mediated pathway and had strong effects on calcium influx in the cell; suggesting, a relatively strong cAMP target. Experiments of α-Pancreatic cells were done in 2mM glucose and 8mM glucose to stimulate hypoglycemia and resting states respectively. Ca<sup>2+</sup> induced Ca<sup>2+</sup> release (CICR) was observed when αMSH was applied with the three PDE inhibitors. When αMSH was applied without a PDE inhibitor there was no increase in [cAMP]<sub>c</sub>, suggesting a micro domain. Extracellular solutions of 2mM glucose with PDE inhibitors such as Milironone, there was influx through N-type and L-type channels and then steady CICR. Rolipram decreased the amount of [Ca<sup><sub>2+</sub></sup>]<sub>c</sub> influx compared to the control, suggesting an inhibitory effect. PDE locations within the cell dictate the level of [cAMP]<sub>c</sub> increase and the influx of [Ca<sup>2+</sup>]<sub>c</sub>.</p>"]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["cAMP and Calcium Interactions in Endocrine Cells"]}]}],"canonical_facts":{"dc:contributor":["Joseph K. Angleson, Ph.D.","Robert Dores","Nancy Lorenzon","Dwight Smith"],"dc:creator":["Crane, Colette"],"dc:date.available":["2001-01-01T08:00:00Z"],"dc:description.abstract":["<p>Inhibitors of cAMP phosphodiestereses (PDEs) promoted an increase in intracellular [cAMP]<sub>c</sub> and an influx of Ca<sup>2+</sup>, in both MMQ pituitary cells and α-Pancreatic cells. The specific targets for PDEs and the domains of PDEs are still unknown. Pituitary MMQ cells were used as a model to test modulation of calcium influx through the L-type calcium channel with PDE inhibitors. cAMP analogs were used to determine cAMP molecular targets. 8-cpt-cAMP initiated an Epac mediated pathway and had strong effects on calcium influx in the cell; suggesting, a relatively strong cAMP target. Experiments of α-Pancreatic cells were done in 2mM glucose and 8mM glucose to stimulate hypoglycemia and resting states respectively. Ca<sup>2+</sup> induced Ca<sup>2+</sup> release (CICR) was observed when αMSH was applied with the three PDE inhibitors. When αMSH was applied without a PDE inhibitor there was no increase in [cAMP]<sub>c</sub>, suggesting a micro domain. Extracellular solutions of 2mM glucose with PDE inhibitors such as Milironone, there was influx through N-type and L-type channels and then steady CICR. Rolipram decreased the amount of [Ca<sup><sub>2+</sub></sup>]<sub>c</sub> influx compared to the control, suggesting an inhibitory effect. PDE locations within the cell dictate the level of [cAMP]<sub>c</sub> increase and the influx of [Ca<sup>2+</sup>]<sub>c</sub>.</p>"],"dc:format":["application/pdf"],"dc:identifier":["https://digitalcommons.du.edu/etd/145"],"dc:language":["en"],"dc:rights":["<p>Copyright is held by the author. User is responsible for all copyright compliance.</p>"],"dc:subject":["Inhibitors of cAMP phosphodiestereses","Modulation of calcium influx","Endocrine cells","Biology","Life Sciences"],"dc:title":["cAMP and Calcium Interactions in Endocrine Cells"],"thesis:degree_level":["Masters Thesis"],"thesis:degree_name":["M.S."]},"updated_at":"2026-07-24T02:03:03Z"}